- Fellowship - University of Michigan Hospitals (2010-2011), Hepatology
- Fellowship - Parkland Health & Hospital System (2007-2010), Gastroenterology
- Residency - University of Michigan Hospitals (2004-2007), Internal Medicine
- Medical School - University of Louisville School of Medicine (2000-2004)
Shannan Tujios, M.D.
- Internal Medicine - Digestive & Liver Diseases
- Liver Transplant Medicine
- Liver Transplant Evaluations
Shannan R. Tujios, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center.
She is American Board of Internal Medicine certified in internal medicine, gastroenterology, and transplant hepatology.
She has delivered many invited lectures, published a number of scholarly articles and abstracts, and co-authored several book chapters. She has also served as a reviewer for Gastroenterology and the Journal of Clinical Gastroenterology.
She was named to the 2016 Press Ganey® Internal Medicine Honor Roll of physicians rated higher than 90 percent for performance.
Dr. Tujios earned her medical degree at the University of Louisville School of Medicine. She completed an internal medicine residency and a transplant hepatology fellowship at University of Michigan Hospitals and a gastroenterology/hepatology fellowship at UT Southwestern/Parkland Health & Hospital System in Dallas.
She joined the UT Southwestern faculty in 2011.
Dr. Tujios is a member of professional organizations that include the American College of Gastroenterology, American Society of Transplantation, American Association for the Study of Liver Disease, and American Society for Gastrointestinal Endoscopy.
Meet Dr. Tujios
Liver Disease Specialist in Dallas
UT Southwestern Medical Center gastroenterologist and hepatologist Dr. Shannan Tujios specializes in evaluating and treating a broad range of liver diseases – from chronic viral hepatitis, fatty liver disease, and autoimmune liver disease to metabolic conditions, portal hypertension, and all types of liver cirrhosis (scarring).
Dr. Tujios also manages patients with end-stage liver disease, evaluates them for liver transplant, and cares for them post-transplant.
“Liver disease affects patients of all ages, and there’s a variety of conditions and severity,” she says.
“It’s really satisfying to see people with early-stage diseases be cured by eradicating or suppressing their underlying conditions. And then, it’s also very gratifying to be able to take patients that have end-stage liver disease and offer transplant as a potential solution.”
Because liver disease impacts the whole body and can overlap with related conditions, Dr. Tujios stresses the importance of UT Southwestern’s multidisciplinary team.
“Caring for patients with liver disease requires a multidisciplinary approach because everyone brings something different to the table,” she says. “My colleagues and I work closely with specialists that include endocrinologists, infectious disease doctors, nutritionists, transplant surgeons – even addiction psychiatrists, in cases where patients with alcohol-related liver disease wish to address their alcohol use.”
Partnering with Patients
Fellowship trained and board certified in internal medicine, gastroenterology, and transplant hepatology, Dr. Tujios enjoys the patient-education part of her work.
“Everybody has a different level of interest and knowledge, but I find that if patients understand a bit about their conditions and why certain things are happening, they’re more likely to follow our recommendations and get better,” she says.
She also takes seriously the role she plays in patients’ lives.
“I treat patients as if they’re an extension of my family and always try to do the best I can for them,” Dr. Tujios says. “People trust physicians to be in their lives and care for them – sometimes when they’re at their most vulnerable – and that’s not something I take lightly.”
- Texas Medical Association
- American Society of Transplantation
- American Society for Gastrointestinal Endoscopy
- American College of Gastroenterology
- American Association for the Study of Liver Disease
Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants.
AbdulRahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, MacConmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019 Mar 25 3 411-424
Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.
Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Hepatology (Baltimore, Md.) 2018 02 67 2 711-720
Transpapillary Gallbladder Stents can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation.
Tujios SR, Rahnama-Moghadam S, Elmunzer JB, Kwon R, Singal AG, Anderson MA, Wamsteker EJ, Taylor JR, Scheiman J, Elta G, Fontana RJ, Piraka CR Journal of clinical gastroenterology 2014 Nov
Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis.
Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJ Digestive diseases and sciences 2012 Mar 57 3 777-85
Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis.
McCarthy ST, Tujios S, Fontana RJ, Rahnama-Moghadam S, Elmunzer BJ, Kwon RS, Wamsteker EJ, Anderson MA, Scheiman JM, Elta GH, Piraka CR, Digestive diseases and sciences 2015 Aug 60 8 2516-22
Risk Factors and Outcomes of Acute Kidney Injury in Patients with Acute Liver Failure.
Tujios SR, Hynan LS, Vazquez MA, Larson AM, Seremba E, Sanders CM, Lee WM Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2014 Jul
Perceived and actual quality of life with ulcerative colitis: a comparison of medically and surgically treated patients.
Waljee AK, Higgins PD, Waljee JF, Tujios SR, Saxena A, Brown LK, Chaudhary MN, Morris AM The American journal of gastroenterology 2011 Apr 106 4 794-9
What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis.
Prokesch BC, Nagalla S, Ezzati F, Tujios SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster J, Martin AA, de la Morena MT, Wysocki CA Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018 Oct
- Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants.
- Liver Transplant Medicine
- Liver Transplant Evaluations
- Liver Disease
- Cancer Screening
Q&A by Dr. Tujios
Showing 1 locations
- Kidney & Liver Disease Clinic - Hepatology (Liver) 7th Floor, Suite 700 214-645-1919
- University Hospital Kidney and Liver Transplant Clinic 7th Floor, Suite 700 214-645-1919